September 25, 2020

The Niche

Knoepfler lab stem cell blog

Liveyon

3 min read

Remember our old friends Liveyon? Their leader John Kosolcharoen? Liveyon’s continuing metamorphosis This biologics supply firm has gone through several stages of corporate metamorphosis as a supplier of biologics including at first a purported living umbilical cord stem cell product. That stem cell thrust ultimately landed a dozen or more people in the hospital as some of the product was somehow contaminated with bacteria along the way before injection in patients. There was a recall, an FDA warning letter, lawsuits, and a voluntary suspension …Read More

4 min read

A new film-commercial entitled Awakening pitches unproven exosomes and has already been possibly tied to the troubled stem cell supplier firm Liveyon, but now it seems that the links go far deeper including a possible relative of Liveyon leader John Kosolcharoen. Even so, Kosolcharoen (pictured with another Liveyon leader Alan Gaveck below in a web video) recently denied involvement in an email exchange with me. Awakening drew so much attention in part because of its strong sci-fi vibe and its implication that the exosome …Read More

4 min read

A new, somewhat mysterious short film that serves as an advertisement for unproven exosomes has some of us scratching our heads. Can you guys as readers of The Niche help solve the puzzle of who’s behind this wild “cinematic commercial” and what the deal is with the unproven exosome product it seemingly promotes as some kind of sci-fi miracle med? I hope so! For more on exosomes and legit research into them see this past guest post. Note that allogeneic exosomes used clinically appear …Read More

5 min read

Every year in December and early January I do a post predicting some key events for the stem cell and regenerative medicine field for the upcoming year and today’s post contains my predictions for 2020. You can see my past 2019 predictions along with my grades for them here. I gave myself a B+ for 2019. What grade will I get for 2020? I don’t yet of course, but I often can’t resist making positive predictions even if they are relatively high risk in …Read More